Blythe Thomson
9Patents
2h-index
10Co-inventors
40Inventor score
Filing activity: Nov 13, 2014 → Mar 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10143704B2 | Methods for treating cancer | Chemistry; Metallurgy | 4 | Active |
| US11497743B2 | Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation | Chemistry; Metallurgy | 3 | Active |
| US11576906B2 | Inhibiting mutant IDH-1 | Human Necessities | 1 | Active |
| US11311527B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) | Human Necessities | 1 | Active |
| US11376246B2 | Inhibiting mutant IDH-1 | Human Necessities | 0 | Active |
| US11963956B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) | Human Necessities | 0 | Active |
| US11013734B2 | Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation | Chemistry; Metallurgy | 0 | Active |
| US11738018B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) | Human Necessities | 0 | Active |
| US11013733B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.